Details
Originalsprache | Englisch |
---|---|
Publikationsstatus | Veröffentlicht - 21 Juli 2017 |
Veranstaltung | ICNAAM 2016, 14th International Conference of Numerical Analysis and Applied Mathematics - Rhodes, Rhodes, Griechenland Dauer: 19 Sept. 2016 → 25 Sept. 2016 Konferenznummer: 14, |
Konferenz
Konferenz | ICNAAM 2016, 14th International Conference of Numerical Analysis and Applied Mathematics |
---|---|
Kurztitel | ICNAAM 2016 |
Land/Gebiet | Griechenland |
Ort | Rhodes |
Zeitraum | 19 Sept. 2016 → 25 Sept. 2016 |
Abstract
Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
ASJC Scopus Sachgebiete
- Physik und Astronomie (insg.)
- Allgemeine Physik und Astronomie
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
2017. Beitrag in ICNAAM 2016, 14th International Conference of Numerical Analysis and Applied Mathematics, Rhodes, Griechenland.
Publikation: Konferenzbeitrag › Paper › Forschung › Peer-Review
}
TY - CONF
T1 - Patentability aspects of computational cancer models
AU - Lishchuk, Iryna
N1 - Conference code: 14,
PY - 2017/7/21
Y1 - 2017/7/21
N2 - Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
AB - Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
UR - http://www.scopus.com/inward/record.url?scp=85026637247&partnerID=8YFLogxK
U2 - 10.1063/1.4992197
DO - 10.1063/1.4992197
M3 - Paper
AN - SCOPUS:85026637247
T2 - International Conference of Numerical Analysis and Applied Mathematics 2016, ICNAAM 2016
Y2 - 19 September 2016 through 25 September 2016
ER -